Urinary Cannabinoid Disposition in Occasional and Frequent Smokers: Is THC-Glucuronide in Sequential Urine Samples a Marker of Recent Use in Frequent Smokers?

被引:39
作者
Desrosiers, Nathalie A. [1 ,2 ]
Lee, Dayong [1 ,2 ]
Concheiro-Guisan, Marta [1 ]
Scheidweiler, Karl B. [1 ]
Gorelick, David A. [1 ]
Huestis, Marilyn A. [1 ]
机构
[1] NIDA, Chem & Drug Metab Sect, IRP, Baltimore, MD 21224 USA
[2] Univ Maryland, Toxicol Program, Baltimore, MD 21201 USA
关键词
ALKALINE-HYDROLYSIS; TEMPORAL INDICATION; ORAL FLUID; METABOLISM; 11-NOR-9-CARBOXY-DELTA(9)-TETRAHYDROCANNABINOL; DELTA(9)-TETRAHYDROCANNABINOL; DELTA-9-TETRAHYDROCANNABINOL; PHARMACOKINETICS; EXCRETION; MARIJUANA;
D O I
10.1373/clinchem.2013.214106
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
BACKGROUND: There is extended urinary excretion of Delta(9)-tetrahydrocannabinol (THC), 11-hydroxy-THC (11-OH- THC), and 11-nor-9-carboxy-THC (THCCOOH) in abstinent frequent cannabis smokers. We characterized THC, 11-OH-THC, THCCOOH, cannabidiol, cannabinol, THC-glucuronide, and THCCOOH-glucuronide disposition in urine of frequent and occasional cannabis smokers, and we propose a model to predict recent cannabis smoking. METHODS: Frequent and occasional smokers resided on a closed research unit and smoked one 6.8% THC cannabis cigarette ad libitum. Urinary cannabinoids were quantified in each void by liquid chromatographytandem mass spectrometry within 24 h of collection. RESULTS: No urine samples had measureable THC, 11-OH- THC, cannabidiol, or cannabinol. THCCOOH, THC-glucuronide, and THCCOOH-glucuronide were measurable in all frequent smokers' urine and 60%, 100%, and 100% of occasional smokers' urine samples, respectively. Pre- and postdose maximal concentrations (non-and creatinine normalized) and probability of being positive were significantly higher in frequent smokers' samples. THC-glucuronide concentrations peaked 0.6-7.4 h after smoking; THCCOOH and THCCOOH-glucuronide concentrations were highly variable. At the newly adopted THCCOOH175-mu g/L World Anti-Doping Agency decision limit, only 50% of frequent smokers were positive 0-6 h postdose; no occasional smokers' samples were positive. An absolute % difference of >= 50% between 2 consecutive THC-glucuronide-positive samples with a creatinine-normalized concentration of >= 2 mu g/g in the first sample predicted cannabis smoking with efficiencies of 93.1% in frequent and 76.9% in occasional smokers within 6 h of first sample collection. CONCLUSIONS: These controlled urinary cannabinoid data provide a possible means of identifying recent cannabis intake in cannabis smokers' urine within a short collection time frame after smoking. (C) 2013 American Association for Clinical Chemistry
引用
收藏
页码:361 / 372
页数:12
相关论文
共 33 条
[1]   Simultaneous GC-El-MS determination of Δ9-tetrahydrocannabinol, 11-hydroxy-Δ9-tetrahydrocannabinol, and 11-nor-9-carboxy, Δ9-tetrahydrocannabinol in human urine following tandem enzyme-alkaline hydrolysis [J].
Abraham, Tsadik T. ;
Lowe, Ross H. ;
Pirnay, Stephane O. ;
Darwin, William D. ;
Huestis, Marilyn A. .
JOURNAL OF ANALYTICAL TOXICOLOGY, 2007, 31 (08) :477-485
[2]  
[Anonymous], FED REG
[3]  
[Anonymous], WORLD DRUG REP 2013
[4]   Impact of enzymatic and alkaline hydrolysis on CBD concentration in urine [J].
Bergamaschi, Mateus M. ;
Barnes, Allan ;
Queiroz, Regina H. C. ;
Hurd, Yasmin L. ;
Huestis, Marilyn A. .
ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2013, 405 (14) :4679-4689
[5]   Impact of Prolonged Cannabinoid Excretion in Chronic Daily Cannabis Smokers' Blood on Per Se Drugged Driving Laws [J].
Bergamaschi, Mateus M. ;
Karschner, Erin L. ;
Goodwin, Robert S. ;
Scheidweiler, Karl B. ;
Hirvonen, Jussi ;
Queiroz, Regina H. C. ;
Huestis, Marilyn A. .
CLINICAL CHEMISTRY, 2013, 59 (03) :519-526
[6]   The urinary disposition of intravenously administered 11-nor-9-carboxy-delta-9-tetrahydrocannabinol in humans [J].
Dietz, Lisa ;
Glaz-Sandberg, Anna ;
Nguyen, Hang ;
Skopp, Gisela ;
Mikus, Gerd ;
Aderjan, Rolf .
THERAPEUTIC DRUG MONITORING, 2007, 29 (03) :368-372
[7]   LC-MS-MS method for simultaneous determination of THCCOOH and THCCOOH-glucuronide in urine: Application to workplace confirmation tests [J].
Felli, M. ;
Martello, S. ;
Chiarotti, M. .
FORENSIC SCIENCE INTERNATIONAL, 2011, 204 (1-3) :67-73
[8]   Interethnic and intraethnic variability of CYP2C8 and CYP2C9 polymorphisms in healthy individuals [J].
Garcia-Martin, Elena ;
Martinez, Carmen ;
Ladero, Jose M. ;
Agundez, Jose A. G. .
MOLECULAR DIAGNOSIS & THERAPY, 2006, 10 (01) :29-40
[9]   Pharmacokinetics of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol (CTHC) after intravenous administration of CTHC in healthy human subjects [J].
Glaz-Sandberg, A. ;
Dietz, L. ;
Nguyen, H. ;
Oberwittler, H. ;
Aderjan, Rolf ;
Mikus, Gerd .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 82 (01) :63-69
[10]   Urinary Elimination of 11-Nor-9-Carboxy-Δ9-tetrahydrocannnabinol in Cannabis Users During Continuously Monitored Abstinence [J].
Goodwin, Robert S. ;
Darwin, William D. ;
Chiang, C. Nora ;
Shih, Ming ;
Li, Shou-Hua ;
Huestis, Marilyn A. .
JOURNAL OF ANALYTICAL TOXICOLOGY, 2008, 32 (08) :562-569